Abstract
Brine shrimp are primitive crustacean arthropodal model organisms, second to daphnia, which can survive in high-salinity environments. Their oviposited cysts, cuticle-covered diapausing eggs, are highly resistant to dryness. To elucidate specialties of brine shrimp, this study characterized glycosphingolipids, which are signal transduction-associated material. A group of novel and complex fucosyl glycosphingolipids were separated and identified from cysts of the brine shrimp Artemia franciscana by repeated lipid extraction, alkaline methanolysis, acid treatment, successive column chromatography, and post-source decay measurements by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Structures of the glycosphingolipids were elucidated by conventional structural characterization and mass spectrometry, and the compounds were identified as GlcNAcβ1-3GalNAcβ1-4(GlcNAcα1-2Fucα1-3)GlcNAcβ1-3Manβ1-4Glcβ1-Cer, GalNAcβ1-4(Fucα1-3)GlcNAcβ1-3GalNAcβ1-4(GlcNAcα1-2Fucα1-3)GlcNAcβ1-3Manβ1-4Glcβ1-Cer, and GalNAcβ1-4(GlcNAcα1-2Fucα1-3)GlcNAcβ1-3GalNAcβ1-4(GlcNAcα1-2Fucα1-3)GlcNAcβ1-3Manβ1-4Glcβ1-Cer. These compounds also contained a branching, non-arthro-series disaccharide with an α-GlcNAc terminus, similar to that found in a previously reported ceramide hexasaccharide (III3(GlcNAcα2Fucα)-At4Cer). The glycans within these complex GSLs are longer than reported glycans of the animal kingdom containing α-GlcNAc terminus. These complex GSLs as well as the longest GSL with ten sugar residues, ceramide decasaccharide (CDeS), contain the fucosylated LacdiNAc sequence reported to associate with parasitism/immunosuppression and the α-GlcNAc terminus reported to show a certain antibacterial effect in other reports. CDeS, the longest GSL of this species, was found in the highest amount, which indicates that CDeS may be functionally important.
Electronic supplementary material
The online version of this article (doi:10.1007/s10719-012-9436-8) contains supplementary material, which is available to authorized users.
Keywords: Sphingosine, Fucomannolipid, Terminal α-N-acetylglucosamine residue, Structure characterization, Branchiopoda, Dormant cyst
Introduction
Glycosphingolipid (GSL) is an amphipathic compound consisting of a sugar chain and a ceramide composed of a fatty acid and sphingoid base. GSLs are ubiquitous on the outer surface of the plasma membrane in animal cells, aggregated into patches called microdomains, and play an essential role in intercellular interaction and recognition [1–3]. However, a comprehensive understanding of GSL function has not yet been attained because of the structural complexity of the sugar chain and ceramide moiety [4, 5].
The study of invertebrate GSLs increases our understanding of human GSLs, helps determine which types of sphingolipids are essential for living animals, and clarifies evolutionary relationships between phyla in the animal kingdom. In the phylum Arthropoda, structural analyses of GSLs have been performed with flies [6, 7], and a characteristic arthro-series sugar chain (GlcNAcβ3Manβ4GlcCer; At3Cer) has been characterized. Functional analyses of GSLs by knockout experiments of egghead and brainiac have shown that At3Cer is essential for insect development [8]. Furthermore, At3Cer was detected in flies, including Lucilia caesar and Calliphora vicina, as well as in arthropods (the millipede Parafontaria laminata armigera) and crustaceans (Euphausia superba, Macrobrachium nipponense) [5]. We have further demonstrated the existence of At3Cer and some shorter GSLs, including GlcCer (CMS), mactosylceramide (MacCer, CDS), II3Fucα-MacCer (nonarthro-CTS), At4Cer (CTeS), II3(GlcNAcα2Fucα)-MacCer (nonarthro-CTeS), III3Fucα-At4Cer (CPS), and III3(GlcNAcα2Fucα)-At4Cer (CHS), in cysts of the brine shrimp Artemia franciscana [9]. However, it is more difficult to identify structural aspects of the sugar chain in complex GSLs than it is in shorter GSLs. Identifying the sugar chain in certain complex GSLs, which may be mixed with GSLs bound to similar oligosaccharides, depends on faint differences in polarity to determine long sugar sequences and the positions of substituted sugar residues at branching points. Several relatively complicated strategies have been employed to identify the structures of complex neutral GSLs, such as successive enzymatic degradation with exoglycosidase, chemical degradation to liberate partial oligosaccharides followed by Gas-liquid chromatography (GC) analysis, and fast atom bombardment (FAB) mass analysis of permethylated GSL to elucidate sugar sequences. In fact, there are relatively few reports that detail the structural analyses of complex GSLs in invertebrates. Complex GSLs have been identified in the green-bottle fly L. caesar and the blowfly C. vicina [10, 11], the human blood fluke Schistosoma mansoni [12–14], the bivalves Corbicula sandai [15] and Hyriopsis schlegeli [16], the seawater bivalve Meretrix lusoria [17], and the oyster Ostrea gigas [5].
The current study uses post-source decay (PSD) measurements coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) to analyze the structures of complex GSLs in diapausing eggs (cysts) of the brine shrimp A. franciscana, a crustacean arthropod harvested from the Great Salt Lake. These complex GSLs contain seven to ten sugar chains and exhibit a hybrid structure of core arthro-series sugar chains with a branching non-arthro-series disaccharide (GlcNAcα2Fucα).
Materials and methods
Separation of ceramide heptasaccharide (CHpS1, CHpS2), ceramide octasaccharide (COS1), and ceramide decasaccharide (CDeS)
Neutral GSL fractions were prepared as previously reported [9] and applied to a column of Iatrobeads (6RS-8060, Mitsubishi Kagaku Iatron Inc. Tokyo). The neutral GSLs were eluted with two linear gradient elution systems of C/M/W with compositions from 80:20:1 (v/v/v, 255 mL) to 50:50:5 (v/v/v, 325 mL) and from 50:50:5 (v/v/v, 252 mL) to 20:80:10 (v/v/v, 330 mL). Three-milliliter fractions were collected in each tube, and aliquots from every third tube were analyzed by high-performance thin-layer chromatography (HPTLC). Fractionated GSLs were analyzed by MALDI-TOF MS. CHpSes are denoted as CHpS1 and CHpS2 according to their order of elution, respectively. Similarly, COSes are denoted as COS1 and COS2.
Separation of COS2 and ceramide nonasaccharide (CNS)
For isolation of COS2 and CNS, an independently prepared neutral GSL fraction (88 mg) was applied to an Iatrobeads column (ϕ1.0 × 56 cm). The neutral GSLs were eluted by a stepwise gradient elution system with one column volume each (44 mL) of pure chloroform, C/M 9:1 (v/v), C/M/W 80:20:1 (v/v/v), 70:30:3, 60:40:4, 50:50:5, 40:60:6, 30:70:7, 20:80:8, 10:90:9, and methanol/water 1:1 (v/v). The C/M/W 20:80:8 fraction including COS2 and CNS was further separated on a HPLC system (Shimadzu LC-10A) with an Iatrobeads column (ϕ1.0 × 55 cm) and eluted with a 75:30:5 (v/v/v) mixture of 1-propanol:water:28 % ammonium hydroxide at a flow rate of 1 mL/min. Three-milliliter fractions were collected in each tube, and aliquots from every third tube were tested by HPTLC. To remove silicic acid from the ammonium column, a brief purification with a Sep-pak C18 cartridge was done as follows: dried crude COS2 and CNS were dissolved in 2 mL of methanol, added to 6 mL of 50 mM NaCl, and applied to a Sep-pak C18 cartridge equilibrated with 25 mL each of water, methanol, and 50 mM NaCl, respectively. The cartridges were desalted with 30 mL of water, and the purified COS2 and CNS were eluted by 10 mL of methanol and dried under a nitrogen stream.
Solvent system for thin-layer chromatography (TLC)
The following solvent systems were used for TLC: C/M/W (60:40:10, v/v/v and 55:45:10, v/v/v) and 1-propanol:water:28 % ammonium hydroxide (1-PrOH/W/NH4OH) (70:30:5, v/v/v). After QAE-Sephadex and Florisil column chromatography, the eluates were visualized on silica gel 60 TLC plates (Merck KGaA, Germany) by spraying with orcinol-H2SO4 reagent [18] followed by heating at 110 °C. To develop isolated GSLs at high resolution, silica gel 60 HPTLC plates (Merck KGaA, Germany) were used after separation on an Iatrobeads column.
Gas chromatography
GC analyses of GSL components, such as sugars, fatty acids, and sphingoids, and methylation procedures were performed as described previously [9]. For the GC analysis, the following amount of GSL was used: 0.2 mg for sugar component analysis, fatty acid analysis, and methylation study, and 0.3 mg for sphingoid analysis.
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)
MALDI-TOF MS analysis was performed using a Shimadzu Axima Confidence MALDI Mass Spectrometer with a nitrogen laser (337 nm). The matrix α-cyano-4-hydroxycinnamic acid (CHCA: high-purity mass-spectrometric grade) was purchased from Shimadzu GLC (Tokyo, Japan). About 4 μg of GSL was loaded on to a MALDI plate and air-dried. Subsequently, 1 μL of CHCA dissolved in 50 % ethanol at a saturating concentration was loaded 4 times on the dried GSL. External mass calibration was provided by the [M+Na]+ ions of angiotensin I (1296.96 mass units; Sigma-Aldrich Co., USA) and bradykinin fragments I–V (573.31 mass units; Sigma-Aldrich Co., USA).
Proton nuclear magnetic resonance spectroscopy (1H-NMR spectroscopy)
Anomeric configurations were confirmed by 1H-NMR as previously reported [9].
Results
Purified neutral glycosphingolipids
Figure 1 shows a developed TLC plate with separated GSLs. The GSLs with less than six sugar residues, corresponding to lanes 2–9 in Fig. 1a, have been previously reported [9]. The yields of purified GSLs obtained from 1.8 kg of brine shrimp cysts were 1.0 mg (CHpS1), 1.3 mg (CHpS2), 1.3 mg (COS1), and 17.7 mg (CDeS). COS2 and CNS were eluted almost simultaneously and with relatively small yields. Therefore, to separate these two lipids, the entire procedure from lipid extraction to purification was repeated with an additional purification step capable of separating COS2 and CNS. The yield of Iatrobeads column chromatography after stepwise elution was as follows: ∼1 mg (lane 2), 5.6 mg (lane 3), 18.6 mg (lane 4), 2.6 mg (lane 5), 10.7 mg (lane 6), 5.5 mg (lane 7), 8.8 mg (lane 8), 8.1 mg (lane 9), 19.3 mg (lane 10), 1.5 mg (lane 11), and 3.3 mg (lane 12) (Fig. 1b). Crude COS2 (1.4 mg) and CNS (∼1 mg) were separated with an eluent of ammoniacal propanol. However, it was revealed in subsequent MALDI-TOF MS spectra that both COS2 and CNS preparations contained silicic acid. Further purification using a Sep-pak C18 cartridge was performed and the resulting lipids were again analyzed by MALDI-TOF MS. The non-GSL fraction was analyzed on the basis of the mass spectrum.
Sugar composition
Each GSL was revealed to be an N-acetyl-O-trimethylsilyl derivatized methylglycoside by GC analysis. Sugar compositions were speculated according to their GCs: CHpS1 and CHpS2 yielded Glc, Man, Fuc, GlcNAc, and GalNAc in a molar ratio of 1:1:1:3:1; COS1 yielded Glc, Man, Fuc, GlcNAc, and GalNAc in a molar ratio of 1:1:1:3:2; and CDeS yielded Glc, Man, Fuc, GlcNAc, and GalNAc in a molar ratio of 1:1:2:4:2 (see Table 1).
Table 1.
Glc | Man | Fuc | GlcNAc | GalNAc | |
---|---|---|---|---|---|
CHpS1 | 1.0 | 1.0 | 0.8 | 3.2 | 1.5 |
CHpS2 | 1.0 | 1.0 | 0.9 | 3.5 | 1.8 |
COS1 | 1.0 | 0.9 | 0.9 | 3.5 | 2.4 |
CDeS | 1.0 | 0.9 | 1.6 | 3.9 | 2.5 |
Methylation analysis
The partially methylated alditol acetates derived from the obtained GSLs were separated by GC, as shown in Fig. 2. The methylation analysis revealed 1,2,5-tri-O-acetyl-3,4-di-O-methylfucitol (1,2Fuc), 1,4,5-tri-O-acetyl-2,3,6-tri-O-methylglucitol (1,4Glc), 1,3,5-tri-O-acetyl-2,4,6-tri-O-methylmannitol (1,3Man), 1,5-di-O-acetyl-3,4,6-tri-O-methyl-N-acetylglucosaminitol (1GlcNAc), 1,5-di-O-acetyl-3,4,6-tri-O-methyl-N-acetylgalactosaminitol (1GalNAc), 1,3,5-tri-O-acetyl-4,6-di-O-methyl-N-acetylglucosaminitol (1,3GlcNAc), and 1,3,4,5-tetra-O-acetyl-6-O-methyl-N-acetylglucosaminitol (1,3,4GlcNAc) from CHpS1; 1,4Glc, 1,3Man, 1,2Fuc, 1GlcNAc, 1,3,5-tri-O-acetyl-4,6-di-O-methyl-N-acetylgalactosaminitol (1,3GalNAc), and 1,3,4GlcNAc from CHpS2; 1,2Fuc, 1,4Glc, 1,3Man, 1GlcNAc, 1GalNAc, 1,4,5-tri-O-acetyl-3,6-di-O-methyl-N-acetylglucosaminitol (1,4GlcNAc), 1,3GalNAc, and 1,3,4GlcNAc from COS1; 1,5-di-O-acetyl-2,3,4-tri-O-methylfucitol (1Fuc), 1,4Glc, 1,3Man, 1GalNAc, 1,3GalNAc, and 1,3,4GlcNAc from COS2; 1Fuc, 1,2Fuc, 1,4Glc, 1,3Man, 1GlcNAc, 1GalNAc, 1,3GalNAc, and 1,3,4GlcNAc from CNS; 1,2Fuc, 1,4Glc, 1,3Man, 1GlcNAc, 1GalNAc, 1,3GalNAc, and 1,3,4GlcNAc from CDeS. 1,4Glc and 1,3Man were eluted at the same retention time and observed as a high peak B. Although methylation analysis of CHpS1 showed the presence of 1,3GalNAc, CHpS1 also contained a small amount of CHpS2 as demonstrated by HPTLC analysis using an ammoniacal solvent (Data not shown).
Aliphatic components
Aliphatic components such as fatty acids and sphingoids were identified by GC (Table 2). The majority of the fatty acids were saturated with chain lengths from C16 to C24, with C22 being the most predominant. The monoenoic acid of C22 was common in all of the GSLs. In some GSLs, the odd-numbered saturated fatty acids C21 and C23 were also detected in low amounts. The sphingoid components of the GSLs were composed of d16:1 and d17:1. In each case, the amount of d16:1 was approximately double that of d17:1.
Table 2.
Fatty acid (%) | CHpS1 | CHpS2 | COS1 | CDeS |
---|---|---|---|---|
16:1 | –b | – | – | tr c |
16:0 | 1.0 | tr | 1.1 | 4.1 |
18:1 | – | – | – | 3.4 |
18:0 | 3.7 | 5.6 | 4.8 | 5.8 |
20:0 | 1.5 | 2.0 | 1.9 | 2.1 |
21:0 | tr | 1.1 | 1.0 | 1.0 |
22:1 | 4.2 | 3.8 | 3.8 | 1.1 |
22:0 | 84.3 | 84.4 | 82.2 | 79.4 |
23:0 | 1.4 | 1.1 | 1.3 | 1.1 |
24:1 | 1.0 | tr | 1.4 | – |
24:0 | 2.9 | 2.0 | 2.5 | 2.0 |
Sphingoid (%) | ||||
d16:1a | 66.7 | 69.3 | 65.7 | 62.3 |
d17:1 | 33.3 | 30.7 | 34.3 | 37.7 |
aDihydroxy sphingoid
bNot detected
cTrace
MALDI-TOF MS analysis
The positive in-source decay mode of MALDI-TOF MS confirmed the putative structures of the six purified GSLs (Fig. 3). Each GSL mass spectrum contained peaks attributed to two major monoisotopic [M+Na]+ ion species, the ceramide moieties of d16:1–22:0 and d17:1–22:0. For CHpS1, these peaks correspond to ions at m/z 1899.47 and 1913.42 with one mole each of Glc, Man, GalNAc, and Fuc and three moles of GlcNAc (Fig. 3a). For CHpS2, the peaks correspond to ions at m/z 1898.82 and 1912.78 with one mole each of Glc, Man, GalNAc, and Fuc and three moles of GlcNAc (Fig. 3b). For COS1, ion peaks at m/z 2101.84 and 2115.81 indicated one mole each of Glc, Man, and Fuc, two moles of GalNAc, and three moles of GlcNAc (Fig. 3c). For COS2, the ion peaks at m/z 2044.96 and 2058.95 corresponded to one mole each of Glc, Man, two moles each of Fuc, GalNAc, and GlcNAc and three moles of GlcNAc (Fig. 3d). For CNS, the ion peaks at m/z 2248.38 and 2262.31 corresponded to one mole each of Glc and Man, two moles of GalNAc and Fuc, and three moles of GlcNAc (Fig. 3e). For CDeS, the ion peaks at m/z 2451.45 and 2465.42 corresponded to one mole each of Glc and Man, two moles of GalNAc and Fuc, and four moles of GlcNAc (Fig. 3f). Detailed masses of ions other than those corresponding to the major [M+Na]+ ion species are summarized in Supplemental table.
The sugar sequence of each GSL was determined by MALDI-TOF PSD measurements, as shown in Fig. 4. The predominant [M+Na]+ ion was chosen as the precursor ion in MALDI-PSD fragment spectra. All fragment ions were observed as sodium adducts. In the PSD mass spectrum of CHpS1, fragment ions showing a neutral loss of sugar were observed at m/z 1697 ([M−HexNAc+Na]+), 1551 ([M−HexNAc−Fuc+Na]+), 1495 ([M−2HexNAc+Na]+), 1348 ([M−2HexNAc−Fuc+Na]+), 1144 ([M−3HexNAc−Fuc+Na]+), 941 ([M−4HexNAc−Fuc+Na]+), and 779 ([M−4HexNAc−Fuc−Hex+Na]+), corresponding to CMS with d16:1/C22:0 (Fig. 4a). In the PSD mass spectrum of CHpS2, fragment ions showing a neutral loss of sugar were observed at m/z 1699 ([M−HexNAc+Na]+), 1551 ([M−HexNAc−Fuc+Na]+), 1496 ([M−2HexNAc+Na]+), 1349 ([M−2HexNAc−Fuc+Na]+), 1292 ([M−3HexNAc+Na]+), 1145 ([M−3HexNAc−Fuc+Na]+), 942 ([M−4HexNAc−Fuc+Na]+), and 779 ([M−4HexNAc−Fuc−Hex+Na]+), corresponding to CMS with d16:1/C22:0 (Supplemental Fig. 1a). In the PSD mass spectrum of COS1, fragment ions showing a neutral loss of sugar were observed at m/z 1901 ([M−HexNAc+Na]+), 1697 ([M−2HexNAc+Na]+), 1494 ([M−3HexNAc+Na]+), 1348 ([M−3HexNAc−Fuc+Na]+), 1145 ([M−4HexNAc−Fuc+Na]+), 941 ([M−5HexNAc−Fuc+Na]+), and 779 ([M−5HexNAc−Fuc−Hex+Na]+), corresponding to CMS with d16:1/C22:0 (Supplemental Fig. 1b). In the PSD mass spectrum of COS2, fragment ions showing a neutral loss of sugar were observed at m/z 1901 ([M−Fuc+Na]+), 1843 ([M−HexNAc+Na]+), 1754 ([M−2Fuc+Na] +), 1697 ([M−HexNAc−Fuc+Na]+), 1552 ([M−HexNAc−2Fuc+Na]+), 1494 ([M−2HexNAc−Fuc+Na]+), 1348 ([M−2HexNAc−2Fuc+Na]+), 1290 ([M−3HexNAc−Fuc+Na]+), 1145 ([M−3HexNAc−2Fuc+Na]+), 941 ([M−4HexNAc−2Fuc+Na]+), and 779 ([M−4HexNAc−2Fuc−Hex+Na]+), corresponding to CMS with d16:1/C22:0 (Supplemental Fig. 1c). In the PSD mass spectrum of CNS, fragment ions showing a neutral loss of sugar were observed at m/z 2104 ([M−Fuc+Na]+), 2047 ([M−HexNAc+Na]+), 1901 ([M−HexNAc−Fuc+Na]+), 1698 ([M−2HexNAc−Fuc+Na]+), 1494 ([M−3HexNAc−Fuc+Na]+), 1348 ([M−3HexNAc−2Fuc+Na]+), 1291 ([M−4HexNAc−Fuc+Na]+), 1144 ([M−4HexNAc−2Fuc+Na]+), 941 ([M−5HexNAc−2Fuc+Na]+), and 779 ([M−5HexNAc−2Fuc−Hex+Na]+), corresponding to CMS with d16:1/C22:0 (Fig. 4b). In the PSD mass spectrum of CDeS, fragment ions showing a neutral loss of sugar were observed at m/z 2250 ([M−HexNAc+Na]+), 2104 ([M−HexNAc−Fuc+Na]+), 2046 ([M−2HexNAc+Na]+), 1900 ([M−2HexNAc−Fuc+Na]+), 1697 ([M−3HexNAc−Fuc+Na]+), 1494 ([M−4HexNAc−Fuc+Na]+), 1348 ([M−4HexNAc−2Fuc+Na]+), 1290 ([M−5HexNAc−Fuc+Na]+), 1144 ([M−5HexNAc−2Fuc+Na]+), 940 ([M−6HexNAc−2Fuc+Na]+), and 778 ([M−6HexNAc−2Fuc−Hex+Na]+), corresponding to CMS with d16:1/C22:0 (Supplemental Fig. 1d).
Anomeric configurations of the sugar residues
Anomeric protons of the sugar residues in CHpSes and CDeS were analyzed by 1H-NMR spectroscopy (Fig. 5 and Table 3). The configurations of these residues were assigned by comparisons with similar data obtained on MacCer and At3Cer [19], At5Cer [20], Fuc [21], and α-GlcNAc [22, 23] (Table 3). The anomeric assignments of α-Fuc and α-GlcNAc were determined by a downfield shift of the glycosyl-substituted fucose peak relative to that in the NMR spectrum of non-arthro-CTS [9], which was consistent with the data of Xu et al. [24]. Anomeric proton resonances are shown in Fig. 5 for each of the GSLs. The glycoside linkages in these compounds were also speculated. In the anomeric region of the spectrum for each GSL, the anomeric proton resonances are observed at 4.16 ppm (J 1,2 = 7.8 Hz) for β-Glc, at 4.52 ppm (J 1,2 = ∼1 Hz) for β-Man, at 4.60 and 4.63 ppm (J 1,2 = 8.2 and 9.1 Hz, respectively) for β-GlcNAc, at 4.29 ppm (J 1,2 = 8.2 Hz) for β-GalNAc, and at 4.99 and 4.98 ppm (J 1,2 = 3.2 and 2.7 Hz) for overlapped α-Fuc and α-GlcNAc (Fig. 5a, CHpS1); at 4.15 ppm (J 1,2 = 7.8 Hz) for β-Glc, at 4.51 ppm (J 1,2 = ∼1 Hz) for β-Man, at 4.58 and 4.65 ppm (J 1,2 = 7.3 and 7.8 Hz, respectively) for β-GlcNAc, at 4.35 ppm (J 1,2 = 7.8 Hz) for β-GalNAc, and at 5.01 and 5.02 ppm (J 1,2 = 3.4 and 3.6 Hz) for overlapped α-Fuc and α-GlcNAc (Fig. 5b, CHpS2); at 4.15 or 4.16 ppm (J 1,2 = 6.4 or 8.7 Hz) for β-Glc, at 4.52 ppm (J 1,2 = ∼1 Hz) for β-Man, at 4.63 and 4.64 ppm (J 1,2 = 7.3 Hz) for β-GlcNAc, at 4.32 and 4.34 ppm (J 1,2 = 6.9 and 7.8 Hz, respectively) for β-GalNAc, at 5.01 ppm (J 1,2 = 2.7 Hz) for overlapped α-Fuc and α-GlcNAc, and 4.84 ppm (J 1,2 =3.7 Hz) for terminal α-Fuc (Fig. 5d, CNS); at 4.15 ppm (J 1,2 = 7.6 Hz) for β-Glc, at 4.51 ppm (J 1,2 = ∼1 Hz) for β-Man, at 4.64 and 4.68 ppm (J 1,2 = 7.2 and 7.4 Hz, respectively) for β-GlcNAc, at 4.34 and 4.37 ppm (J 1,2 = 8.0 and 8.1 Hz, respectively) for β-GalNAc, and at 5.02 ppm (J 1,2 = 2.9 Hz) for overlapped α-Fuc and α-GlcNAc (Fig. 5e, CDeS). As for COS2, purity was low that significant high signals attributable to a contaminant were observed at the olefin signal region. Although precise coupling constants could not be calculated, anomeric configuration and sugar species of COS2 were annotated according to chemical shift by comparing other NMR spectra of Artemia GSLs.
Table 3.
CHpS1 | GalNAc1-3,4 | (GlcNAc1- | 2Fuc1-3,4) | GlcNAc1- | 3GlcNAc1- | 3Man1- | 4Glc1 | |||
II | V | V | IV | IV | III | I | ||||
Chemical shifts (ppm) | 4.29 | 4.98 | 4.98 | 4.60 | 4.60 | 4.52 | 4.16 | |||
4.99 | 4.99 | 4.63 | 4.63 | |||||||
Coupling constants (Hz) | 8.2 | 2.7 | 2.7 | 8.2 | 8.2 | ∼1 | 7.8 | |||
3.2 | 3.2 | 9.1 | 9.1 | |||||||
CHpS2 | GlcNAc1-3 | GalNAc1-4 | (GlcNAc1- | 2Fuc1-3) | GlcNAc1- | 3Man1- | 4Glc1 | |||
IV | II | V | V | IV | III | I | ||||
Chemical shifts (ppm) | 4.58 | 4.35 | 5.01 | 5.01 | 4.58 | 4.51 | 4.15 | |||
4.65 | 5.02 | 5.02 | 4.65 | |||||||
Coupling constants (Hz) | 7.3 | 7.8 | 3.4 | 3.4 | 7.3 | ∼1 | 7.8 | |||
7.8 | 3.6 | 3.6 | 7.8 | |||||||
CNS | GalNAc1-4 | (Fuc1-3) | GlcNAc1-3 | GalNAc1-4 | (GlcNAc1- | 2Fuc1-3) | GlcNAc1- | 3Man1- | 4Glc1 | |
II | VI | IV | II | V | V | IV | III | I | ||
Chemical shifts (ppm) | 4.32 | 4.84 | 4.63 | 4.32 | 5.01 | 5.01 | 4.63 | 4.52 | 4.15 | |
4.34 | 4.64 | 4.34 | 4.64 | 4.16 | ||||||
Coupling constants (Hz) | 6.9 | 3.7 | 7.3 | 6.9 | 2.7 | 2.7 | 7.3 | ∼1 | 6.4 | |
7.8 | 7.3 | 7.8 | 7.3 | 8.7 | ||||||
CDeS | GalNAc1-4 | (GlcNAc1- | 2Fuc1-3) | GlcNAc1-3 | GalNAc1-4 | (GlcNAc1- | 2Fuc1-3) | GlcNAc1- | 3Man1- | 4Glc1 |
II | V | V | IV | II | V | V | IV | III | I | |
Chemical shifts (ppm) | 4.34 | 5.02 | 5.02 | 4.64 | 4.34 | 5.02 | 5.02 | 4.64 | 4.51 | 4.15 |
4.37 | 4.68 | 4.37 | 4.68 | |||||||
Coupling constants (Hz) | 8.0 | 2.9 | 2.9 | 7.2 | 8.0 | 2.9 | 2.9 | 7.2 | ∼1 | 7.6 |
8.1 | 7.4 | 8.1 | 7.4 |
Speculated structures of the complex GSLs
The following complex GSL structures were speculated by means of the conventional analyses plus MALDI PSD measurements: IV3-(GlcNAcβ)-III3-(GlcNAcα2Fucα)-At4Cer (CHpS2), IV3-(fucosyl-LacdiNAc)-III3-(GlcNAcα2Fucα)-At4Cer (CNS), and IV3-(2-α-N-acetylglucosaminylfucosyl-LacdiNAc)-III3-(GlcNAcα2Fucα)-At4Cer (CDeS). The following complex GSL structures were also analyzed: IV3,4-(GalNAcβ)-IV3,4-(GlcNAcα2Fucα)-At4Cer (CHpS1), GalNAc1-3,4(GlcNAc1-3,4)GlcNAc1-2Fuc1-3GalNAc1-4GlcNAc1-3Man1-4Glc1-Cer (COS1), and IV3- (fucosyl-LacdiNAc)-III3-(Fucα)-At4Cer (COS2). Although “1,3,4GlcNAc” was observed as a branching GlcNAc in both CHpS1 and COS1, it was impossible to confirm sugar substitution at the C3/C4 position without hydrolysis analysis, which requires a large amount of CHpS1 and COS1.
Discussion
Structural characterization of complex GSLs can be a painstaking process because the results obtained by different analyses must converge on a single structure. For example, characterization by liquid chromatography-mass spectrometry (LC-MS) and tandem MS (MS-MS) provides accurate mass values of ceramide moieties, fatty acids, and sphingoids, but not of sugar species. It is also possible that liquid chromatographic separation would not be able to fully separate GSLs with different sugar chains of identical molecular weight. The conventional analyses, which consist of GC and MS, can be used to determine sugar species and molar ratios without overlooking the possibility of GSLs with different sugar chains of identical molecular weight. Another benefit of the conventional analysis is the ability to determine branching structures by hydrolysis. No matter the analysis, it is difficult to characterize complex GSLs because each result is also complex. A few decades ago, characterization of a complex GSL required 10 mg of isolated GLS for chemical degradation, which liberated shorter GSLs, followed by GC analysis to determine sugar sequence and exoglycosidase treatment or chromic acid oxidation to determine anomeric configurations. In this study, we conducted MALDI PSD analysis to determine sugar sequence and 1H-NMR spectroscopy to identify anomeric configurations by using only 1-mg samples of each complex GSL separated from A. franciscana. Although PSD spectra of complex GSLs were confusing, sugar sequence analysis using sequences speculated from fragments, with the ceramide moiety observed in the high mass region, were consistent with sequences speculated from mere glycan fragments observed in the low mass region.
This study examined the structures of complex GSLs separated from the brine shrimp A. franciscana. Of them, a fucosylated LacdiNAc trisaccharide structure (GalNAcβ1-4[Fucα1-3]GlcNAcβ) was found in CHpS2, COS2, CNS, and CDeS, similar to a previous report on CHS [9]. The trisaccharide structure is an analog of Lewis X and is also found in GSLs from the parasite S. mansoni [25] and in the carbohydrate portion of a human immunosuppressive glycoprotein, glycodelin [26].
The arthro-series core structure and a branching non-arthro-series disaccharide were also found in CHpS2, CNS, and CDeS, as described in previous reports on nAtCTeS and CHS. The α-anomeric GlcNAc residue is rare, and there have been few reports of this residue among the carbohydrate portions of GSLs and glycoproteins. A human gastric mucin with an α-anomeric GlcNAc residue could arrest the proliferation of Helicobacter pylori [27].
We speculate that CHpS2 is elongated with an additional Fucα group, forming COS, and that COS is further elongated with branching GalNAcβ to form CNS. Although we could not separate COS as a direct precursor of CNS, we believe it exists in the biosynthetic pathway (Fig. 6). CNS is then finally elongated with an additional GlcNAcα to form CDeS. However, another branching residue on CHpS1 and COS1 indicates other biosynthetic pathways. A. franciscana GSLs with α-anomeric GlcNAc at the nonreducing end do not seem to be elongated with further saccharides, which suggests the action of a “capping” mechanism. This theory is further supported by the observation that all of the α-anomeric GlcNAc residues were reported at the nonreducing end [9, 22–24, 28, 29]. Capping by an amino sugar in A. franciscana GSLs may be similar to the capping action of the 2-keto-3-deoxy-d-glycero-d-galacto-nononic acid (KDN) residue in the rainbow trout Salmo gairdneri [30].
A series of structural analyses, including this study, has established the existence of sphingomyelin as a sphingophospholipid and GlcCer, MacCer, At3Cer, II3Fucα-MacCer (non-arthro-CTS), At4Cer, II3(GlcNAcα2Fucα)-MacCer (non-arthro-CTeS), III3Fucα-At4Cer (CPS), III3(GlcNAcα2Fucα)-At4Cer (CHS), CHpS1, CHpS2, COS1, COS2, CNS, and CDeS as GSLs of A. franciscana. The complex GSLs reported this time are as the novel fucomannolipids. However, we confirmed that gangliosides and their functional alternative materials (other acidic GSLs) were below the limit of detection. In mammals, acidic GSLs such as gangliosides play important roles in the formation of the plasma membrane surface environment for signal transduction. It is interesting that A. franciscana can survive without significant amounts of acidic GSLs.
Performing structural analyses of complex GSLs in A. franciscana cysts, which are developmentally diapaused gastrulae, we established a GSL profile during embryonic development. Similar GSL analyses have been carried out in other species, including the frog Xenopus laevis [31], the chicken Gallus gallus domesticus [32], and the mouse Mus musculus [33]. However, all of these studies were conducted during the neurula stage or later, emphasizing the importance of timing in our study. A. franciscana is a very suitable organism for studying GSL profiles during early embryogenesis, as they require 5 days from fertilization to the gastrula stage.
In the brine shrimp A. franciscana, there are two reproduction patterns: oviparity, which generates diapausing eggs (cysts), and ovoviviparity, which generates nauplii. Oviparous eggs are resistant to dryness due to the existence of the heat shock protein p26 [34], which seems to be induced by environmental factors than by temperature. Nambu et al. [35] conducted experiments showing that certain conditions of light/dark cycles and temperature could affect the reproduction pattern of brine shrimp. GSLs have been shown to be involved in signaling, and signal transduction is, at least in part, responsible for the choice of oviparity or ovoviviparity. Therefore, this study, which provides a comprehensive analysis of GSLs in embryonic A. franciscana, might be of major significance in studies of embryogenesis and signal transduction.
A. franciscana contains complex GSLs such as CDeS, CHpSes, and COSes. Other invertebrates containing complex GSLs with more than five sugar residues are [5] the flies L. caesar, C. vicina, Drosophila melanogaster (Insecta), the parasitic nematode Ascaris suum (Nematoda), the liver fluke Fasciola hepatica, the blood fluke S. mansoni (Platyhelminthes: Trematoda), the pseudophyllidean tapeworm Spirometra erinacei, the tapeworm Diphyllobothrium hottai (Platyhelminthes: Cestoda), the earthworm Pheretima hilgendorfi (Annelida: Oligochaeta), the annelidan worm Pseudopotamilla occelata (Annelida: Polychaeta), the bivalves H. schlegeli, C. sandai, M. lusoria, the oyster O. gigas (Mollusca), the abalone Haliotis japonica (Mollusca: Gatropoda), the lamp shell Lingula unguis (Brachiopoda), and the sea urchin Hemicentrotus pulcherrimus (Echinodermata). Of these, only half contain GSLs with the same number of sugar residues and a different sugar chain sequence. As in vertebrates, GSLs with multiple sugar chain sequences may exhibit tissue specificity. These GSLs can be roughly divided into two groups: one with straight complex GSLs, such as those found in flies, the nematode, the blood fluke, and the lamp shell, and those with branching complex GSLs. Complex GSLs with more than seven sugar residues have been reported as follows: GlcNAcβ1-3Galβ1-3GalNAcα1-4GalNAcβ1-4GlcNAcβ1-3Manβ1-4Glcβ1-Cer (At7Cer) from the fly C. vicina [11]; At7Cer, VII3-β-GalNAc-At7Cer (At8Cer), and VIII3-β-Gal-At8Cer (At9Cer) from the fly L. caesar [10]; Fucα3GalNAcβ4(Fucα3)GlcNAcβ3GlcNAcβ3GalNAcβ4GlcβCer, Fucα3GalNAcβ4(Fucα2Fucα3)GlcNAcβ3GlcNAcβ3GalNAcβ4GlcβCer, Fucα3GalNAcβ4(Fucα2Fucα2Fucα3)GlcNAcβ3GlcNAcβ3GalNAcβ4GlcβCer, and Fuc1-4(Fuc1-3)GlcNAc1-2Fuc1-4(Fuc1-3)GlcNAc1-2Fuc1-4(Fuc1-3)GlcNAc1-2Fuc1-4(Fuc1-3)GlcNAc1-3GalNAc1-3GalNAc1-4Glc1-Cer from the blood fluke [12–14]; Gal4Meβ1-3GalNAcβ1-3Fucα1-4GlcNAcβ1-2Manα1-3(Xylβ1-2)Manβ1-4Glcβ1-Cer (GL-1) from the bivalve C. sandai [15]; Fuc3Meα1-2Xyl3Meβ1-4(GalNAc3Meα1-3)Fucα1-4GlcNAcβ1-2Manα1-3(Xylβ1-2)Manβ1-4Glcβ1-Cer (Lipid III) from the bivalves H. schlegeli and M. lusoria [16, 17]; and GlcNAc1-3(Fuc3Meα1-2)Gal1-4GalNAc1-3[GalNAc3Me1-3(Fucα1-2)Gal1-2]Galβ1-3Galβ1-4Glcβ1-Cer from the oyster [5]. All of these GSLs, with the exception of those found in the flies, contain a branching sugar chain and at least one fucose residue. In addition, almost all of the molluscan GSLs contain xylose and an O-methyl sugar residue. Organisms can also be divided into two groups according to the presence or absence of acidic or polar GSLs. The former group includes the flies and the bivalves. The latter group contains A. franciscana, the blood fluke, and the oyster. Furthermore, a fucosylated LacdiNAc structure and a GlcNAcβ1-3GlcNAc disaccharide are common to both A. franciscana and the blood fluke. Shorter GSLs seem to be conserved within the same phyla while longer GSLs are more commonly unique to a given species.
This study of the entire GSL structure in A. franciscana showed that the ceramide composition is common among nearly all neutral GSLs, irrespective of the length of the sugar chain, with the exception of CMS, which contains hydroxy fatty acid, similar to millipedes [21], but not to flies such as L. caesar and C. vicina [6, 7, 10, 11, 36]. In arthropods, the dominant ceramide moieties are d16:1 and smaller amounts of d17:1 as sphingoid; C22:0 and smaller amounts of C18:0 as fatty acid in A. franciscana; d17:1 and smaller amounts of branched d18:1 as sphingoid; C22:0 and smaller amounts of C23:0/C24:0 as fatty acid in the millipede; d14:1 and smaller amounts of d16:1 as sphingoid; C20:0 and smaller amounts of C18:0/C22:0 as fatty acid in the flies and in the High Five insect cell line derived from the cabbage looper Trichoplusia ni [37]. As mentioned above, the ceramide composition is found in both A. franciscana and the millipede, especially odd-numbered sphingoids, with the highest amount being C22:0. In addition, all of the neutral GSLs isolated from flies were straight, while the millipede contained a branching neutral GSL [21] and a ceramide phosphoryl ethanolamine (CPEA) [38] instead of the polar GSL with a molecular group of phosphoryl-ethanolamine, as found in flies [5]. A. franciscana contained branching neutral GSLs and sphingomyelin instead of a sphingolipid with a phosphoryl-ethanolamine group [39]. This commonality might indicate that A. franciscana is more closely related to the millipede than to insects.
Currently, it is not possible to use molecular biological approaches in brine shrimp because its genome has not been sequenced. However, there has been a report detailing the RNAi knockdown of a homeotic gene using microinjection [40]. It has been speculated that glycosyltransferases could be found in the arthropodal genomic sequences of D. melanogaster and other species, which might aid in the elucidation of a relationship between morphogenesis and the functions of GSLs in Crustacea.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Acknowledgments
We would like to thank Prof. Mutsumi Sugita and Prof. Akemi Suzuki for helpful comments. We also thank Mr. Masahiro Sakane for additional experiments. This work was supported in part by the Grant-in-Aid for Scientific Research (C) (No. 22500276) and a grand of Strategic Research Foundation Grant-aided Project for Private Universities (No. S1001042).
Open Access
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Abbreviations
- CDeS
Ceramide decasaccharide
- CHpS
Ceramide heptasaccharide
- CHS
Ceramide hexasaccharide
- CNS
Ceramide nonasaccharide
- COS
Ceramide octasaccharide
- GC
Gas chromatography
- GSL
Glycosphingolipid
- 1H-NMR
Proton nuclear magnetic resonance
- HPTLC
High-performance thin-layer chromatography
- MALDI-TOF MS
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
References
- 1.Hakomori S. Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain. Glycoconj. J. 2000;17:143–151. doi: 10.1023/A:1026524820177. [DOI] [PubMed] [Google Scholar]
- 2.Yu RK, Nakatani Y, Yanagisawa M. The role of glycosphingolipid metabolism in the developing brain. J. Lipid Res. 2009;50:S440–S445. doi: 10.1194/jlr.R800028-JLR200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 1997;278:1626–1629. doi: 10.1126/science.278.5343.1626. [DOI] [PubMed] [Google Scholar]
- 4.Yu RK, Yanagisawa M, Ariga T. Glycosphingolipid structures. In: Kamerling JP, editor. Comprehensive Glycoscience from Chemistry to Systems Biology1: Introduction to Glycoscience; Synthesis of Carbohydrates. Oxford: Elsevier; 2007. pp. 73–122. [Google Scholar]
- 5.Itonori S, Sugita M. Glycophylogenetic aspects of lower animals. In: Kamerling JP, editor. Comprehensive Glycoscience from Chemistry to Systems Biology 3: Biochemistry of Glycoconjugate Glycans; Carbohydrate-Mediated Interactions. Oxford: Elsevier; 2007. pp. 253–284. [Google Scholar]
- 6.Sugita M, Nishida M, Hori T. Studies on glycosphingolipids of larvae of the green-bottle fly, Lucilia caesar. I. Isolation and characterization of glycosphingolipids having novel sugar sequences. J. Biochem. 1982;92:327–334. doi: 10.1093/oxfordjournals.jbchem.a133938. [DOI] [PubMed] [Google Scholar]
- 7.Dennis RD, Geyer R, Egge H, Menges H, Stirm S, Wiegandt H. Glycosphingolipids in insects. Chemical structures of ceramide monosaccharide, disaccharide, and trisaccharide from pupae of Calliphora vicina (Insecta: Diptera) Eur. J. Biochem. 1985;146:51–58. doi: 10.1111/j.1432-1033.1985.tb08618.x. [DOI] [PubMed] [Google Scholar]
- 8.Müller R, Altmann F, Zhou D, Hennet T. The Drosophila melanogaster brainiac protein is a glycolipid-specific β1,3N-acetylglucosaminyltransferase. J. Biol. Chem. 2002;277:32417–32420. doi: 10.1074/jbc.C200381200. [DOI] [PubMed] [Google Scholar]
- 9.Kojima H, Shimizu T, Sugita M, Itonori S, Fujita N, Ito M. Biochemical studies on sphingolipids of Artemia franciscana: Novel neutral glycosphingolipids. J. Lipid Res. 2011;52:308–317. doi: 10.1194/jlr.M010173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sugita M, Inagaki F, Naito H, Hori T. Studies on glycosphingolipids in larvae of the green-bottle fly, Lucilia caesar: Two neutral glycosphingolipids having large straight oligosaccharide chains with eight and nine sugars. J. Biochem. 1990;107:899–903. doi: 10.1093/oxfordjournals.jbchem.a123145. [DOI] [PubMed] [Google Scholar]
- 11.Dennis R, Geyer R, Egge H, Peter-Katalinic J, Li S, Stirm S, Wiegandt H. Glycosphingolipids in insects; chemical structures of ceramide tetra-, penta-, hexa-, and heptasaccharide from Calliphora vicina pupae (Insecta: Diptera) J. Biol. Chem. 1985;260:5370–5375. [PubMed] [Google Scholar]
- 12.Levery SB, Weiss JB, Salyan ME, Roberts CE, Hakomori S, Magnani JL, Strand M. Characterization of a series of novel fucose-containing glycosphingolipid immunogens from eggs of Schistosoma mansoni. J. Biol. Chem. 1992;267:5542–5551. [PubMed] [Google Scholar]
- 13.Khoo KH, Chatterjee D, Caulfield JP, Morris HR, Dell A. Structural characterization of glycosphingolipids from the eggs of Schistosoma mansoni and Schistosoma japonicum. Glycobiology. 1997;7:653–661. doi: 10.1093/glycob/7.5.653. [DOI] [PubMed] [Google Scholar]
- 14.Wuhrer M, Kantelhardt SR, Dennis RD, Doenhoff MJ, Lochnit G, Geyer R. Characterization of glycosphingolipids from Schistosoma mansoni eggs carrying Fuc(α1-3)GalNAc-, GalNAc(β1-4)[Fuc(α1-3)]GlcNAc- and Gal(β1-4)[Fuc(α1-3)]GlcNAc- (Lewis X) terminal structures. Eur. J. Biochem. 2002;269:481–493. doi: 10.1046/j.0014-2956.2001.02673.x. [DOI] [PubMed] [Google Scholar]
- 15.Itasaka O, Kosuga M, Okayama M, Hori T. Characterization of a novel ceramide octasaccharide isolated from whole tissue of a fresh-water bivalve, Corbicula sandai. Biochim. Biophys. Acta. 1983;750:440–446. doi: 10.1016/0005-2760(83)90183-2. [DOI] [PubMed] [Google Scholar]
- 16.Hori T, Sugita M, Ando S, Kuwahara M, Kumauchi K, Sugie E, Itasaka O. Characterization of a novel glycosphingolipid, ceramide nonasaccharide, isolated from spermatozoa of the fresh water bivalve Hyriopsis schlegelii. J. Biol. Chem. 1981;256:10979–10985. [PubMed] [Google Scholar]
- 17.Sugita M, Nakae H, Yamamura T, Takamiya Y, Itasaka O, Hori T. The occurrence of glycosphigolipids containing mannose in the sea-water bivalve, Meretrix lusoria. J. Biochem. 1985;98:27–34. doi: 10.1093/oxfordjournals.jbchem.a135268. [DOI] [PubMed] [Google Scholar]
- 18.Svennerholm L. The quantitative estimation of cerebrosides in nervous tissue. J. Neurochem. 1956;1:42–53. doi: 10.1111/j.1471-4159.1956.tb12053.x. [DOI] [PubMed] [Google Scholar]
- 19.Schwientek T, Keck B, Levery SB, Jensen MA, Pedersen JW, Wandall HH, Stroud M, Cohen SM, Amado M, Clausen H. The drosophila gene brainiac encodes a glycosyltransferase putatively involved in glycosphingolipid synthesis. J. Biol. Chem. 2002;277:32421–32429. doi: 10.1074/jbc.M206213200. [DOI] [PubMed] [Google Scholar]
- 20.Chen Y, Pedersen JW, Wandall HH, Levery SB, Pizette S, Clausen H, Cohen SM. Glycosphingolipids with extended sugar chain have specialized functions in development and behavior of Drosophila. Dev. Biol. 2007;306:736–749. doi: 10.1016/j.ydbio.2007.04.013. [DOI] [PubMed] [Google Scholar]
- 21.Sugita M, Hayata C, Yoshida T, Suzuki M, Suzuki A, Takeda T, Hori T, Nakatani F. A novel fucosylated glycosphingolipid from the millipede Parafontaria laminata armigera. Biochim. Biophys. Acta. 1994;1215:163–169. doi: 10.1016/0005-2760(94)90106-6. [DOI] [PubMed] [Google Scholar]
- 22.Costantino V, D’Esposito M, Fattorusso E, Mangoni A, Basilico N, Parapini S, Taramelli D. Damicoside from Axinella damicornis: The influence of a glycosylated galactose 4-OH group on the immunostimulatory activity of α-galactoglycosphingolipids. J. Med. Chem. 2005;48:7411–7417. doi: 10.1021/jm050506y. [DOI] [PubMed] [Google Scholar]
- 23.Wuhrer M, Grimm C, Zähringer U, Dennis RD, Berkefeld CM, Idris MA, Geyer R. A novel GlcNAcα1-HPO3-6Gal(1-1)ceramide antigen and alkylated inositol-phosphoglycerolipids expressed by the liver fluke Fasciola hepatica. Glycobiol. 2003;13:129–137. doi: 10.1093/glycob/cwg005. [DOI] [PubMed] [Google Scholar]
- 24.Xu X, Horibata Y, Inagaki M, Hama Y, Sakaguchi K, Goda HM, Okino N, Ito M. A novel fucosyl glycosphingolipid of brine shrimp that is highly sensitive to endoglycoceramidase. Glycobiol. 2009;19:1446–1451. doi: 10.1093/glycob/cwp118. [DOI] [PubMed] [Google Scholar]
- 25.Nyame AK, Yoshino TP, Cummings RD. Differential expression of LacdiNAc, fucosylated LacdiNAc, and Lewis X glycan antigens in intramolluscan stages of Schistosoma mansoni. J. Parasitol. 2002;88:890–897. doi: 10.1645/0022-3395(2002)088[0890:DEOLFL]2.0.CO;2. [DOI] [PubMed] [Google Scholar]
- 26.Dell A, Morris HR, Easton RL, Panico M, Patankar M, Oehninger S, Koistinen R, Koistinen H, Seppala M, Clark GF. Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities J. Biol. Chem. 1995;270:24116–24126. doi: 10.1074/jbc.270.41.24116. [DOI] [PubMed] [Google Scholar]
- 27.Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda NM, Fukuda M, Katsuyama T, Nakayama J. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science. 2004;305:1003–1006. doi: 10.1126/science.1099250. [DOI] [PubMed] [Google Scholar]
- 28.Ishihara K, Kurihara M, Goso Y, Urata T, Ota H, Katsuyama T, Hotta K. Peripheral α-linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: epitope recognized by a newly characterized monoclonal antibody. Biochem. J. 1996;318:409–416. doi: 10.1042/bj3180409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Nakayama J, Yen JC, Misra AK, Ito S, Katsuyama T, Fukuda M. Expression cloning of a human α1,4-N-acetylglucosaminyltransferase that forms GlcNAcα1→4Galβ→R, a glycan specifically expressed in the gastric gland mucous cell-type mucin. Proc. Natl. Acad. Sci. USA. 1999;96:8991–8996. doi: 10.1073/pnas.96.16.8991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Nadano D, Iwasaki M, Endo S, Kitajima K, Inoue S, Inoue Y. A naturally occurring deaminated neuraminic acid, 3-deoxy-D-glycero-D-galacto-nonulosonic acid (KDN). Its unique occurrence at the nonreducing ends of oligosialyl chains in polysialoglycoprotein of rainbow trout eggs. J. Biol. Chem. 1986;261:11550–11557. [PubMed] [Google Scholar]
- 31.Okamura N, Kishimoto Y. Changes in nervous system glycolipids during metamorphosis of Xenopus laevis. J. Biol. Chem. 1983;258:12243–12246. [PubMed] [Google Scholar]
- 32.Rosner H, Al-Aqtum M, Rahmann H. Gangliosides and neuronal differentiation. Neurochem. Int. 1992;20:339–351. doi: 10.1016/0197-0186(92)90048-V. [DOI] [PubMed] [Google Scholar]
- 33.Ngamukote S, Yanagisawa M, Ariga T, Ando S, Yu RK. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. J. Neurochem. 2007;103:2327–2341. doi: 10.1111/j.1471-4159.2007.04910.x. [DOI] [PubMed] [Google Scholar]
- 34.Liang P, Macrae TM. The synthesis of a small heat shock/α-Crystallin protein in Artemia and its relationship to stress tolerance during development. Dev. Biol. 1999;207:445–456. doi: 10.1006/dbio.1998.9138. [DOI] [PubMed] [Google Scholar]
- 35.Nambu Z, Tanaka S, Nambu F. Influence of photoperiod and temperature on reproductive mode in the brine shrimp, Artemia franciscana. J. Exp. Zool. 2004;301A:542–546. doi: 10.1002/jez.a.80. [DOI] [PubMed] [Google Scholar]
- 36.Sugita M, Iwasaki Y, Hori T. Studies on glycosphingolipids of larvae of the green-bottle fly, Lucilia caesar. II. Isolation and structural studies of three glycosphingolipids with novel sugar sequences. J. Biochem. 1982;92:881–887. doi: 10.1093/oxfordjournals.jbchem.a134002. [DOI] [PubMed] [Google Scholar]
- 37.Fuller MD, Schwientek T, Wandall HH, Pedersen JW, Clausen H, Levery SB. Structure elucidation of neutral, di-, tri-, and tetraglycosylceramides from High Five cells: identification of a novel (non-arthro-series) glycosphingolipid pathway. Glycobiol. 2005;15:1286–1301. doi: 10.1093/glycob/cwj011. [DOI] [PubMed] [Google Scholar]
- 38.Hori T, Hayata C, Nakatani F, Yoshida T, Sugita M. Occurrence of sphingoethanolamine in millipede Parafontaria laminata armigera. Bull. Shiga Bunka Coll. 1993;3:71–78. [Google Scholar]
- 39.Kojima H, Inoue T, Sugita M, Itonori S, Ito M. Biochemical studies on sphingolipid of Artemia franciscana (I) isolation and characterization of sphingomyelin. Lipids. 2010;45:635–643. doi: 10.1007/s11745-010-3438-8. [DOI] [PubMed] [Google Scholar]
- 40.Copf T, Schröder R, Averof M. Ancestral role of caudal genes in axis elongation and segmentation. Proc. Natl. Acad. Sci. USA. 2004;101:17711–17715. doi: 10.1073/pnas.0407327102. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.